At TD2, we are revolutionizing oncology research through an integrated ecosystem that brings together preclinical services, advanced flow cytometry, robust regulatory support, an extensive …

Choosing TD2 means selecting a dedicated partner that combines scientific rigor with strategic vision. Our comprehensive oncology ecosystem and collaborative approach ensure your drug …

TD2 Oncology accelerates preclinical drug development with a robust suite of in vivo and in vitro tumor model systems and advanced bioanalytical services, designed to generate clinically …

In the 4.5 years I have worked at TD2, I have been very impressed with the continued growth of the company. This is due in large part to the outstanding leadership team as well as the highly …

Jun 4, 2020 · The acquisition of TD2 by RCT will be a catalyst to expand and accelerate TD2’s platform of integrated oncology solutions and to position TD2 as the leader in strategic …

HAVE A QUESTION? Contact Our Experts GET STARTED Ask us how you can get your oncology medicine to market faster with TD2. Get Started Now

Jul 29, 2025 · The partnership combines TD2’s proven oncology execution capabilities with Curadh’s deep scientific innovation in the radiopharmaceutical space, accelerating the …

Sep 4, 2024 · TD2 continues to be a trusted partner in the pharmaceutical and biotech industry, offering a wide range of services, including preclinical and clinical trial management, …

At TD2 Oncology, we provide comprehensive clinical research solutions tailored specifically for oncology. From trial design and feasibility through site management, data analysis, and final …

Discover TD2's advanced preclinical flow cytometry services for oncology research. Our platform offers comprehensive immunophenotyping, drug mechanism analysis, and high-throughput …